I agree that this site is using cookies. You can find further informations here.
X
Sill, Carol
27  results:
Search for persons X
?
1

Electricanada:

K-M, James ; Sill, Carol
Leonardo.  33 (2000)  5 - p. 440-441 , 2000
Link: https://doi.org/10.1162/..
 
?
2

Gallery Artworks:

Trott, Michael ; Reas, Casey ; Banks, Anne Marie...
Leonardo.  33 (2000)  5 - p. 403-427 , 2000
Link: https://doi.org/10.1162/..
 
?
3

Pembrolizumab versus placebo in addition to carboplatin and..:

Eskander, Ramez ; Sill, Michael ; Beffa, Lindsey...
Gynecologic Oncology.  176 (2023)  - p. S42-S43 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Bevacizumab plus fosbretabulin in recurrent ovarian cancer:..:

Tewari, Krishnansu S. ; Sill, Michael W. ; Coleman, Robert L....
Gynecologic Oncology.  159 (2020)  1 - p. 79-87 , 2020
Link: https://doi.org/10.1016/..
 
?
5

A randomized phase II study of cabozantinib versus weekly p..:

Matulonis, Ursula A. ; Sill, Michael W. ; Makker, Vicky...
Gynecologic Oncology.  152 (2019)  3 - p. 548-553 , 2019
Link: https://doi.org/10.1016/..
 
?
6

Safety lead-in of the MEK inhibitor trametinib in combinati..:

Westin, Shannon N. ; Sill, Michael W. ; Coleman, Robert L....
Gynecologic Oncology.  155 (2019)  3 - p. 420-428 , 2019
Link: https://doi.org/10.1016/..
 
?
7

Randomized phase II trial of bevacizumab plus everolimus ve..:

Tew, William P. ; Sill, Michael W. ; Walker, Joan L....
Gynecologic Oncology.  151 (2018)  2 - p. 257-263 , 2018
Link: https://doi.org/10.1016/..
 
?
8

Randomized phase IIB evaluation of weekly paclitaxel versus..:

Cohn, David E. ; Sill, Michael W. ; Walker, Joan L....
Gynecologic Oncology.  146 (2017)  3 - p. 477-483 , 2017
Link: https://doi.org/10.1016/..
 
?
9

A phase 2 study of alisertib (MLN8237) in recurrent or pers..:

Hyman, David M ; Sill, Michael W ; Lankes, Heather A...
Gynecologic Oncology.  144 (2017)  1 - p. 96-100 , 2017
Link: https://doi.org/10.1016/..
 
?
10

A phase II evaluation of the potent, highly selective PARP ..:

Coleman, Robert L. ; Sill, Michael W. ; Bell-McGuinn, Katherine...
Gynecologic Oncology.  137 (2015)  3 - p. 386-391 , 2015
Link: https://doi.org/10.1016/..
 
?
11

Iniparib plus paclitaxel and carboplatin as initial treatme..:

Aghajanian, Carol ; Sill, Michael W. ; Secord, Angeles Alvarez..
Gynecologic Oncology.  126 (2012)  3 - p. 424-427 , 2012
Link: https://doi.org/10.1016/..
 
?
12

Pembrolizumab plus Chemotherapy in Advanced Endometrial Can..:

Eskander, Ramez N ; Sill, Michael W ; Beffa, Lindsey...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351614/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
13

BEVACZIUMAB PLUS FOSBRETABULIN IN RECURRENT OVARIAN CANCER:..:

Tewari, Krishnansu S ; Sill, Michael W ; Coleman, Robert L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789907/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
14

Randomized Phase II Trial of Nivolumab Versus Nivolumab and..:

Zamarin, Dmitriy ; Burger, Robert A ; Sill, Michael W...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255977/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
15

Bevacizumab plus fosbretabulin in recurrent ovarian cancer:..:

Tewari, Krishnansu S ; Sill, Michael W ; Coleman, Robert L...
qt4gv9d1r9.  , 2020
Link: https://escholarship.org..
 
1-15